{"id":"https://openalex.org/W2168043326","doi":"https://doi.org/10.3109/03639049009114903","title":"Simple Prediction of Stability Constants for Inclusion Complexes of \u03b2-Cyclodextrin with various Drug Molecules Using \u03b2-Cyclodextrin Bonded Phases(Cyclobond I Column)","display_name":"Simple Prediction of Stability Constants for Inclusion Complexes of \u03b2-Cyclodextrin with various Drug Molecules Using \u03b2-Cyclodextrin Bonded Phases(Cyclobond I Column)","alternate_titles":[],"publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W2168043326","doi":"https://doi.org/10.3109/03639049009114903","mag":"2168043326"},"language":"en","primary_location":{"id":"doi:10.3109/03639049009114903","doi":"https://doi.org/10.3109/03639049009114903","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639049009114903","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2168043326"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046126993","display_name":"Mingxin Wang","orcid":"https://orcid.org/0000-0001-8367-7970","observed_orcids":["https://orcid.org/0000-0001-8367-7970"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]},{"id":"https://openalex.org/I4210109619","display_name":"National Institutes of Pharmaceutical Research and Development (China)","ror":"https://ror.org/024zcda42","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210109619"]}],"countries":["CN","JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mingxin Wang","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome, , Shinagawa-ku, Tokyo 142, Japan; China National Institute of Pharmaceutical R&D, , P.O. Box 948, Beijing, 100083, (china)","China National Institute of Pharmaceutical R&D,, P.O. Box 948, Beijing, 100083, (china)","Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome,, Shinagawa-ku, Tokyo 142, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome, , Shinagawa-ku, Tokyo 142, Japan; China National Institute of Pharmaceutical R&D, , P.O. Box 948, Beijing, 100083, (china)","institution_ids":["https://openalex.org/I36296616","https://openalex.org/I4210109619"]},{"raw_affiliation_string":"China National Institute of Pharmaceutical R&D,, P.O. Box 948, Beijing, 100083, (china)","institution_ids":["https://openalex.org/I4210109619"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome,, Shinagawa-ku, Tokyo 142, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103443099","display_name":"Haruhisa Ueda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Haruhisa Ueda","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome,, Shinagawa-ku, Tokyo 142, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome,, Shinagawa-ku, Tokyo 142, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111816164","display_name":"Tsuneji Nagai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tsuneji Nagai","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome,, Shinagawa-ku, Tokyo 142, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Hoshi University, 4-41, Ebara 2-chome,, Shinagawa-ku, Tokyo 142, Japan","institution_ids":["https://openalex.org/I36296616"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4227,"has_fulltext":false,"cited_by_count":7,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.44382716,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"3","first_page":"571","last_page":"579"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-cyclodextrin","display_name":"\u03b2-cyclodextrin","score":0.9649999737739563},{"id":"https://openalex.org/keywords/inclusion-complexes","display_name":"inclusion complexes","score":0.9549999833106995},{"id":"https://openalex.org/keywords/stability-constants","display_name":"stability constants","score":0.9769999980926514},{"id":"https://openalex.org/keywords/sulfonamides","display_name":"sulfonamides","score":0.8999999761581421},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9990000128746033},{"id":"https://openalex.org/keywords/retention-time","display_name":"retention time","score":0.6769999861717224},{"id":"https://openalex.org/keywords/solubility-method","display_name":"solubility method","score":0.8019999861717224},{"id":"https://openalex.org/keywords/drug-prediction","display_name":"drug prediction","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.9138152599334717},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6879957318305969},{"id":"https://openalex.org/C2778649806","wikidata":"https://www.wikidata.org/wiki/Q261310","display_name":"Inclusion compound","level":3,"score":0.5640250444412231},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.5433046221733093},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.533744215965271},{"id":"https://openalex.org/C2780586882","wikidata":"https://www.wikidata.org/wiki/Q7520643","display_name":"Simple (philosophy)","level":2,"score":0.4820743203163147},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41634631156921387},{"id":"https://openalex.org/C168191866","wikidata":"https://www.wikidata.org/wiki/Q4551818","display_name":"Stability constants of complexes","level":3,"score":0.4119876027107239},{"id":"https://openalex.org/C186399102","wikidata":"https://www.wikidata.org/wiki/Q903517","display_name":"Chemical stability","level":2,"score":0.41015076637268066},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.39365291595458984},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.33141595125198364},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.3202654719352722},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.1205669641494751},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1201275885105133},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06008294224739075},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3109/03639049009114903","doi":"https://doi.org/10.3109/03639049009114903","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639049009114903","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},{"id":"doi:10.3109/03639049009104403","doi":"https://doi.org/10.3109/03639049009104403","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639049009104403","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.4000000059604645,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1591073419","https://openalex.org/W1999583460","https://openalex.org/W2028909872","https://openalex.org/W2036106040","https://openalex.org/W2074277929","https://openalex.org/W2079595115","https://openalex.org/W2320084935","https://openalex.org/W2322047817","https://openalex.org/W2326287562","https://openalex.org/W2331556649","https://openalex.org/W2411711440","https://openalex.org/W4250329688"],"related_works":["https://openalex.org/W2322047817","https://openalex.org/W2224800502","https://openalex.org/W2375216202","https://openalex.org/W2725965641","https://openalex.org/W6945386943","https://openalex.org/W2363446445","https://openalex.org/W2010895015","https://openalex.org/W2094203557","https://openalex.org/W2956320939","https://openalex.org/W2007256135"],"abstract_inverted_index":{"The":[0,28,55],"stability":[1],"constants(Kc)":[2],"for":[3],"inclusion":[4],"complexes":[5],"of":[6,31,57,77],"cyclodextrin":[7,25],"with":[8],"sulfonamides,":[9],"sulfonylureas":[10],"and":[11],"p-aminobenzoic":[12],"acid":[13],"esters":[14],"were":[15,60],"investigated":[16],"by":[17,47,69],"high":[18],"performance":[19],"liquid":[20],"chromatography":[21],"(HPLC)":[22],"using":[23,73],"the":[24,48,62,78],"bonded":[26],"phase.":[27],"retention":[29],"time(Rt)":[30],"these":[32],"drugs":[33],"on":[34],"a":[35,40,70,74],"Cyclobond\u00ae":[36],"I":[37],"column":[38],"showed":[39],"good":[41],"relationship":[42],"to":[43],"K,":[44,63],"values":[45,64],"obtained":[46],"solubility":[49],"method":[50,59],"and/or":[51],"conventional":[52],"HPLC":[53],"method.":[54],"advantages":[56],"this":[58],"that":[61],"could":[65],"be":[66],"rapidly":[67],"predicted":[68],"simple":[71],"procedure":[72],"minimum":[75],"quantity":[76],"drugs.":[79]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2168043326","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
